Long-term outcome and pre-interventional predictors for late intervention after uterine fibroid embolization

Uterine leiomyomas are the most common benign tumors of the uterus with a premenopausal cumulative clinically relevant incidence of 50% in black and 35% in white women [1]. The standard treatment for symptomatic fibroids is hysterectomy, but there has been a shift towards less invasive approaches like myomectomy, high intensity focused ultrasound and UFE [1 –3]. Mid- and long-term studies evaluating therapy effectiveness after UFE suggest freedom from treatment failure between 70%-90%, based on follow-up times between 1 and 10 years [2,3,5–9]; however, follow-up data longer than 10 years after UFE are scarce as well as preinterventional factors predicting higher risk for treatment failure and late conversion to surgery.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Review article Source Type: research